Scientia Press

Originating in Eastern Europe, Halotherapy uses aerosol microparticles of salt to treat respiratory conditions.  While it has shown effectiveness against asthma, bronchitis, and other chronic respiratory conditions, there is evidence that HT is also effective as prophylaxis against respiratory infections.  In this video, Viktoria Nagudi discusses with Kenneth Dillon of Scientia Press the history, modalities, applications, and potential benefits of HT in the context of the COVID-19 pandemic, including for reopening the economy and schools.  See also https://www.scientiapress.com/halotherapy.

Halotherapy versus COVID-19

Concerned over shortages of face masks, U.S. medical authorities initially discouraged the use of face masks by the public.  But a good deal of evidence (Jefferson T 2007) shows that face masks reduced the risk of infection by 68% in SARS, an analogue of COVID-19.  This suggests that wearing face masks can go far toward slowing the spread of the pandemic.  Therefore, we need to find a way to provide enough of them not just to protect medical personnel but also to protect the public.  Reusing them seems a very attractive strategy.